Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-18

Clinical Trial Update: Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CxL Combined With Photorefractive Keratectomy (PRK) in Keratoconus [NA]

View source ↗

Summary

This clinical trial update reports on blurring strength and aberrometric changes after corneal cross-linking (CxL) alone and in combination with photorefractive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Democritus University of Thrace | Conditions: Keratoconus | NA | Status: COMPLETED